Preemptive Medicine for Dementia
In June 2021, aducanumab, the first drug to target the cause of Alzheimer’s disease, was approved in the US, making headlines worldwide. We look at the results of clinical trials…
In June 2021, aducanumab, the first drug to target the cause of Alzheimer’s disease, was approved in the US, making headlines worldwide. We look at the results of clinical trials…
Prevention to cure! The groundbreaking world of Japanese medical technology and healthcare. From food and exercise to the latest treatments.
FIND OUT MORE
A Mayo Clinic cardiologist explains how they could save your life.
READ ORIGINAL ARTICLE
WhatsApp us